The record
Written from the 1 report below. Nothing here is unsourced.
- Government laboratories found 220 drug samples that failed to meet established quality standards during August 2026 testing.
- Authorities identified 29 samples as Not of Standard Quality at the central level and 191 at the state level.
- A separate sample collected in Delhi was classified as counterfeit due to the unauthorized use of another brand's name.
- Ongoing investigations aim to address the manufacturing of these substandard and illicit medicines.
Coverage1
1 report
Indian-language1
All filed from India
Named India · Delhi · ANI · Asmita Tripathi · Central Drugs Standard Control Organisation
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.